ArticleNeuroscience bulletin2026
Task-Based fMRI Reveals a Diagnosis-Dependent Amygdala Lateralization in Major Depressive Disorder, Borderline Personality Disorder, and Comorbidities.
Article in Neuroscience bulletin, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study examined whether major depressive disorder (MDD) and borderline personality disorder (BPD) comorbidity (MDD-BPD) represents an additive pathophysiology or a distinct neurobiological entity using amygdala-focused neuroimaging. Participants (n = 217) underwent fMRI during an emotional face-matching task. An independent clinical sample (n = 1,032) was applied to identify comorbidity bridging factors. Mediation analysis examined whether each comorbidity factor independently mediated the association between amygdala functional lateralization and comorbid diagnostic status. BPD-only patients showed right-lateralized amygdala hyperreactivity, which was absent in the MDD-only group, and the MDD-BPD group exhibited bilateral amygdala activation. The combined BPD group (BPD-only and MDD-BPD) showed bilateral amygdala hyperreactivity versus controls, whereas combined MDD groups (MDD-only and MDD-BPD) exhibited left-lateralized hyperreactivity. Two comorbidity bridging factors (emotional instability and negative self-concept) were identified, and each independently mediated the relationship between amygdala lateralization and comorbidity. Cumulatively, MDD-BPD comorbidity represents a neurobiologically distinct diagnosis-dependent syndrome characterized by disorder-specific amygdala activation patterns and transdiagnostic psychological vulnerability.
Indexed as
Identifiers
42771073What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.